Suppr超能文献

眼睑皮脂腺癌中CTNNB1基因及ras通路基因KRAS、NRAS、BRAF和PIK3CA的突变分析

Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.

作者信息

Kwon Mi Jung, Nam Eun Sook, Cho Seong Jin, Park Hye-Rim, Min Soo Kee, Seo Jinwon, Choe Ji-Young

机构信息

Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang-si, Gyeonggi-do 431-070, Republic of Korea.

Department of Pathology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 134-701, Republic of Korea.

出版信息

Pathol Res Pract. 2017 Jun;213(6):654-658. doi: 10.1016/j.prp.2017.02.015. Epub 2017 Mar 1.

Abstract

Sebaceous carcinoma (SC) represents a rare, aggressive eyelid malignancy with poor prognosis and is a possible component of Muir-Torre syndrome. However, genetic features as driver mutations or potential therapeutic targets are not fully elucidated. Recent a few studies have shown that SCs have concurrently multiple mutations including RAS/RAF/MAPK and PI3K/Akt pathways via next-generation sequencing in western population. Because we recently demonstrated absence of KRAS mutations in Korean eyelid SCs, we extended our previous study to the analysis of NRAS, BRAF, PIK3CA, and CTNNB1 mutations, and the examination of related protein expressions in 15 eyelid SCs. Repeated molecular analysis by peptide nucleic acid-mediated PCR clamping method, PNA clamping-assisted fluorescence melting curve analysis, and direct sequencing revealed that all eyelid SCs had wild type alleles of NRAS, BRAF, and PIK3CA in hotspot exon locations. Only silent mutations in the CTNNB1 gene (p.Q61Q) were identified. Using immunohistochemistry and microsatellite instability analysis, they harbored all intact mismatch repair gene proteins with microsatellite stability. Membranous and cytoplasmic β-catenin staining was found in all tumors, whereas the one third of those tumors showed cyclin D1 overexpression, of which 40% and 80% showed p53 expression and p16 expression, respectively. The lack of KRAS, NRAS, BRAF, and PIK3CA mutation in our study may suggest that a subset of eyelid SCs is unlike that of eyelid SCs of western countries. The mismatch repair gene proteins and microsatellite instability analysis as a screening test for Muir-Torre syndrome may be limited in the Korean eyelid SCs.

摘要

皮脂腺癌(SC)是一种罕见的侵袭性眼睑恶性肿瘤,预后较差,是穆尔-托里综合征的可能组成部分。然而,作为驱动突变或潜在治疗靶点的基因特征尚未完全阐明。最近的一些研究表明,在西方人群中,通过二代测序发现皮脂腺癌同时存在包括RAS/RAF/MAPK和PI3K/Akt通路在内的多种突变。由于我们最近证明韩国眼睑皮脂腺癌不存在KRAS突变,因此我们将之前的研究扩展至对15例眼睑皮脂腺癌中NRAS、BRAF、PIK3CA和CTNNB1突变的分析以及相关蛋白表达的检测。通过肽核酸介导的PCR钳夹法、PNA钳夹辅助荧光熔解曲线分析和直接测序进行的重复分子分析显示,所有眼睑皮脂腺癌在热点外显子位置均具有NRAS、BRAF和PIK3CA的野生型等位基因。仅鉴定出CTNNB1基因的沉默突变(p.Q61Q)。通过免疫组织化学和微卫星不稳定性分析,它们均具有完整的错配修复基因蛋白且微卫星稳定。在所有肿瘤中均发现膜性和细胞质β-连环蛋白染色,而其中三分之一的肿瘤显示细胞周期蛋白D1过表达,其中40%和80%的肿瘤分别显示p53表达和p16表达。我们研究中缺乏KRAS、NRAS、BRAF和PIK3CA突变可能表明一部分眼睑皮脂腺癌与西方国家的眼睑皮脂腺癌不同。错配修复基因蛋白和微卫星不稳定性分析作为穆尔-托里综合征的筛查试验在韩国眼睑皮脂腺癌中可能有限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验